Physician profile
Andrew Phillips
NPI 1669829248
$17,357.60
in general payments reported to CMS, 2019-2025
40 companies · $5,174 in 2025
The $5,174 reported for 2025 was more than what 94% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $150 · 2021: $339 · 2022: $1,874 · 2023: $3,919 · 2024: $5,288 · 2025: $5,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,811.97 |
| Travel and Lodging | $568.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,056.85 | 2022-2025 | Proclaim, Eterna |
| Medtronic, INC. | $4,251.04 | 2022-2025 | Vanta Adaptivestim, Synchromedii, Intellis Adaptivestim |
| Spinal Simplicity, LLC | $2,379.44 | 2024-2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $697.79 | 2025 | Senza, Omnia |
| Curonix LLC | $560.34 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $513.33 | 2021-2025 | General - Pain Management, Intracept, General - Therapies |
| Nevro Corp. | $411.45 | 2022 | |
| Abbvie INC. | $355.51 | 2023-2025 | |
| Allergan, INC. | $321.94 | 2019-2022 | |
| Saluda Medical Americas, INC. | $302.35 | 2023-2025 | Evoke, Evoke Scs |
| Merz North America, INC. | $268.41 | 2019 | |
| Collegium Pharmaceutical, INC. | $249.67 | 2021-2025 | Belbuca, Xtampza |
| Lundbeck LLC | $229.52 | 2021-2025 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.64 | 2021-2024 | Relistor |
| Stryker Corporation | $186.42 | 2024 | Mild Device Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.